Mountain Valley MD Holdings Inc. (MVMDF) Stock
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors. Its portfolio includes Quicksome, an advanced oral drug formulation and delivery system; Quicksol, a technology designed to improve solubility; and a dose-sparing adjuvant. Currently, the company is also progressing with the development of IM032, a treatment being tested in male beagle dogs to assess the differences between intramuscular and subcutaneous administration routes. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Mountain Valley MD Holdings Inc. is headquartered in CA.
Mountain Valley MD Holdings Inc. (MVMDF) stock trades at $0.06 with a market capitalization of $19.70M. The stock is valued at a price-to-earnings (P/E) ratio of -9.37, price-to-book of -187.42, price-to-sales of 406.56. Over the past 52 weeks the stock has ranged between $0.01 and $0.09, and currently trades 33.3% below its 52-week high.
On profitability, Mountain Valley MD Holdings Inc. generates a return on equity (ROE) of -314.49%, return on capital employed of -890.84%, an operating margin of -2446.15%, a net profit margin of 0.00%.
Official website: www.mvmd.com